TWST
Twist Bioscience Corporation
Diagnostics & Research · Healthcare · United States
152.78
close · 2026-10-30
value
21
cheaper than peers21
quality
41
stronger fundamentals41
ranked against
Diagnostics & Research
value
quality
31 peers
Value inputs
| measure | company | vs peers |
| earnings yield, 2 years ago | -2.4% | 50 |
| earnings yield, 3 years ago | -2.6% | 45 |
| earnings yield, latest year | -0.9% | 44 |
| earnings yield, 1 year ago | -2.4% | 40 |
| cash flow yield, 1 year ago | -0.7% | 37 |
| cash flow yield, 3 years ago | -2.2% | 37 |
| cash flow yield, 2 years ago | -1.7% | 37 |
| cash flow yield, latest year | -0.7% | 34 |
| price to book | 21.48× | 16 |
| price to sales | 23.46× | 11 |
10 of 12 measures available
Quality inputs
| measure | company | vs peers |
| revenue growth | 23.2% | 79 |
| debt to equity | 24.4% | 74 |
| return on equity | -29.6% | 19 |
| operating margin | -30.6% | 12 |
4 of 4 measures available
Facts
| market cap | $10B |
| free cash flow | -$64.8M |
| employees | 979 |
| first trade | 2018-10-31 |
| next earnings | 2026-11-12 |
| fundamentals updated | 2026-08-05 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -1.30 | -3.60 | -3.60 | -4.04 |
| free cash flow | -$75.6M | -$69.2M | -$170.3M | -$226.2M |
| net income | -$77.7M | -$208.7M | -$204.6M | -$217.9M |
| revenue | $376.6M | $313.0M | $245.1M | $203.6M |
| unusual items | $48.8M | -$44.9M | -$10.3M | $18.9M |